SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Kuhlmann Shirley R.

(Last) (First) (Middle)
C/O COLLEGIUM PHARMACEUTICAL, INC.
780 DEDHAM STREET, SUITE 800

(Street)
CANTON MA 02021

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2018
3. Issuer Name and Ticker or Trading Symbol
COLLEGIUM PHARMACEUTICAL, INC [ COLL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and General Counsel
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
No securities beneficially owned 0 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Shirley R. Kuhlmann 03/26/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY



       KNOW ALL BY THESE PRESENTS, that the undersigned hereby

constitutes and appoints Paul Brannelly and Michael T. Heffernan

with full power to act singly, as the undersigned's true and

lawful attorneys-in-fact, with full power of substitution, to:



1) execute for and on behalf of the undersigned, in the

undersigned's capacity as an officer and/or director and/or

beneficial owner of Collegium Pharmaceutical, Inc.

(the "Company"), Forms 3, 4, and 5 in accordance with Section

16(a) of the Securities Exchange Act of 1934, as amended, and

the rules thereunder;



2) do and perform any and all acts for and on behalf of the

undersigned which may be necessary or desirable to complete

and execute any such Form 3, 4, or 5, complete and execute

any amendment or amendments thereto, and timely file such

form with the United States Securities and Exchange

Commission and any stock exchange or similar authority; and



3) take any other action of any type whatsoever in connection

with the foregoing which,in the opinion of such attorney-in-fact,

may be of benefit to, in the best interest of, or legally required

by, the undersigned, it being understood that the documents executed

by such attorney-in-fact on behalf of the undersigned pursuant to

this Power of Attorney shall be in such form and shall contain such

terms and conditions as such attorney-in-fact may approve in such

attorney-in-fact's discretion.



      The undersigned hereby grants to the attorney-in-fact full

power and authority to do and perform any and every act and thing

whatsoever requisite, necessary or proper to be done in the exercise

of any of the rights and powers herein granted, as fully to all

intents and purposes as the undersigned might or could do if personally

present with full power of substitution or revocation, hereby ratifying

and confirming all that such attorney-in-fact or such attorney-in-fact's

substitute or substitutes, shall lawfully do or cause to be done by

virtue of this power of attorney and the rights and powers herein

granted.



       This power of attorney shall remain in full force and effect

until revoked by the undersigned in a signed writing delivered to

the attorney-in-fact.



       IN WITNESS WHEREOF, the undersigned has caused this Power of

Attorney to be executed as of this 26th day of March, 2018.



   By:  /s/ Shirley R. Kuhlmann

   Name:  Shirley R. Kuhlmann

   Title:  EVP and General Counsel